Biggest News Aggregation in the World
๐Ÿ“ฐ Highly Selective News

Page 2 - Highly Selective News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Highly Selective. Real-time updates on events, politics, business and more.

ORIC Pharmaceuticals to Present Initial Phase 1b Clinical Data for ORIC 114 in EGFR/HER2 Exon 20 Mutated NSCLC at the European Society of Medical Oncology (ESMO) Congress 2023

17.10.2023 - Company to host a conference call and webcast on Saturday, October 21, 2023, at 9:00 am ET featuring Dr. Alexander Spira to discuss initial data and potential of ORIC-114 in EGFR/HER2 mutated cancersSOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Oct. ...
United States South San Francisco San Diego Alexander Spira Pharmaceuticals Inc Global Phase

ORIC Pharmaceuticals to Present Initial Phase 1b Clinical Data for ORIC 114 in EGFR/HER2 Exon 20 Mutated NSCLC at the European Society of Medical Oncology (ESMO) Congress 2023

Company to host a conference call and webcast on Saturday, October 21, 2023, at 9:00 am ET featuring Dr. Alexander Spira to discuss initial data and potential of ORIC-114 in EGFR/HER2 mutated...
United States South San Francisco San Diego Alexander Spira Dominic Piscitelli Pharmaceuticals Inc

Tenaya Therapeutics Presents Encouraging New Clinical and Preclinical Data from HDAC6 Inhibitor Program TN-301 for the Potential Treatment of Heart Failure with Preserved Ejection Fraction at the 2023 HFSA Annual Scientific Meeting

TN-301 Demonstrates Tolerability, Potential for Once Daily Dosing, Target Engagement and Selectivity for HDAC6 in Phase 1 Clinical Trial of Healthy Participantsย 
United States Whit Tingley Tenaya Therapeutics Inc Administration Of Inhibitors Heart Failure Society Of America Tenaya Therapeutics

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Exploring the Inclusion of eDiscovery-Centric Resources in the Google C4 Dataset: A Highly Selective Search | EDRM - Electronic Discovery Reference Model

[EDRM Editorโ€™s Note: This article was first published here on April 26, 2023 and EDRM is grateful to Rob Robinson, editor and managing director of ComplexDiscovery, for permission to...
United States Washington Post Discovery Centric Resources Highly Selective Colossal Clean Crawled Corpus Common Crawl

A Phase 1 Clinical Trial Evaluating Monotherapy With Exarafenib (KIN-2787), a Highly Selective Pan-RAF Inhibitor, in BRAF‑Altered Solid Tumors and NRAS-Mutant Melanoma

Alexander I. Spira, MD, PhD, shares new dose escalation data from the first-in-human Phase 1 KIN-2787 study of the pan-RAF inhibitor exarafenib in patients with BRAF-altered solid tumors or NRAS-mutant melanoma.
Alexanderi Spira Highly Selective Altered Solid Tumors Pan Raf Inhibitor Braf Altered Solid Tumors Nras Mutant Melanoma

IBC Advanced Technologies, Inc.: IBC Produces 99.5+% Lithium Hydroxide Monohydrate Product from Brine at Salar de Maricunga, Chile using Direct Lithium to Product (DLP) Process

AMERICAN FORK, Utah, April 25, 2023 /PRNewswire/ -- IBC Advanced Technologies, Inc. ("IBC") announces production of 99.5+% lithium hydroxide monohydrate ("LiOH.H2O") product at its Direct Lithium
United States Salar De Maricunga Iii Region Stevenr Izatt Grupo Errazuriz Technologies Inc

MyJournals.org - Science - '[ASAP] Dual Synthetic Receptor-Based Sandwich Electrochemical Sensor for Highly Selective and Ultrasensitive Detection of Pathogenic Bacteria at the Single-Cell Level' (Analytical Chemistry)

MyJournals.org - Science - [ASAP] Dual Synthetic Receptor-Based Sandwich Electrochemical Sensor for Highly Selective and Ultrasensitive Detection of Pathogenic Bacteria at the Single-Cell Level (Analytical Chemistry)
Dearomative Diels Electrical Stimulation Industrial Engineering Chemistry Research Highly Selective Ultrasensitive Detection Pathogenic Bacteria Single Cell Level

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science